Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
210 participants
INTERVENTIONAL
2011-01-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
210 parturients will be randomized to one of three groups: Arnica montana C6 and Bellis perennis C6 (n=70), Arnica montana C30 and Bellis perennis C30 (n=70), or double placebo (n=70).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bryophyllum vs. Nifedipine
NCT00391339
Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
NCT03625518
The Impact of Bryophyllum on Preterm Delivery
NCT00163579
Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth
NCT05110599
Effect of Hyoscine- Bromide on Duration of the First Stage of Labor
NCT06056869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Homeopathy 1
Arnica montana C6 and Bellis perennis C6
Homeopathy 1
Arnica montana C6 and Bellis perennis C6
Homeopathy 2
Arnica montana C30 and Bellis perennis C30
Homeopathy 2
Arnica montana C30 and Bellis perennis C30
Placebo
globules identical to true comparators
Placebo
globule identical to true homeopathy comparators
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Homeopathy 1
Arnica montana C6 and Bellis perennis C6
Homeopathy 2
Arnica montana C30 and Bellis perennis C30
Placebo
globule identical to true homeopathy comparators
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 20-35
* second to fifth gestation
* spontaneous PV delivery
* term delivery (37-42nd weeks)
Exclusion Criteria
* multifetal pregnancy
* history of bleeding problems
* caesarian section delivery
* chorioamnionitis
* pregnancy-induced hypertension
* gestational diabetes mellitus
* polyhydramnios, premature rupture of membrane
* suspected macrosomy/SGA
20 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaare Zedek Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Menachem Oberbaum
Director, Center for Integrative Complementary Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maternity Ward, Shaare Zedek Medical Center
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ArBel.2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.